NEW YORK, August 21, 2018 /PRNewswire/ --
According to data published by Research and Markets, the North American legal cannabis market value is projected to reach
approximately USD 35 Billion by 2023 while registering a strong CAGR of 27.1%. The North American
legal cannabis market has already surpassed the USD 8 Billion mark in terms of value in 2017. The
report also specifies that cannabis is gaining prominence in the North American region because of increasing favorable views in
regards of products for both recreational and medical uses. As a result of continued legalization and indications of demand, an
influx of investments into research and development has occurred, which in turn leads to innovation. CLS Holdings USA Inc. (OTC: CLSH), Aurora Cannabis Inc. (OTC: ACBFF), iAnthus Capital Holdings Inc. (OTC: ITHUF), Emerald
Health Therapeutics Inc. (OTC: EMHTF), General Cannabis Corp. (OTC: CANN)
Citing a report from Deloitte, nearly two-thirds of current cannabis consumers are likely to buy cannabis products from a
legal channel. Jennifer Lee, Partner, Cannabis National Leader, and Consumer Advisory and
Analytics Practice National Leader, said, "Most current and likely cannabis consumers want a variety of products offered at
reasonable prices from suppliers who can vouch for the safety and origin of those products. Cannabis companies will need to have
secure supply chains to protect the quality and integrity of their products, and retailers will need to meet consumer
expectations, including providing a positive, engaging retailing experience and protecting the privacy of their customers,
especially online."
CLS Holdings USA Inc. (OTCQB: CLSH) last week announced the issuance of the following
statement to CLS partners, shareholders and other stakeholders from its Chairman and Chief Executive Officer, Jeff Binder:
"I reach out to all members of the CLS family today with gratitude, pride and excitement. Gratitude and pride for the
dedication and support of our employees, partners and shareholders in our accomplishments to date, and great excitement for the
value I see for us in the path ahead. It's been an extremely busy and productive past few months for our CLS team and we believe
we are now in a great position to build long-term shareholder value.
Over the past 45 days, we have closed on two oversubscribed funding rounds. A Canadian round of CAD
13.0 Million and a U.S. round of USD 5.75 Million. We are encouraged that our financial
backers share the excitement and vision we have for CLS. Navy Capital, one of our lead funds, has a vast network of relationships
in the cannabis industry and is extremely interested in the CLS patented extraction and processing technology. We look forward to
the added value that Navy Capital brings to CLS. It is a terrific corporate development to have an additional partner, of Navy
Capital's stature, and we are excited by the expertise they bring to CLS. We now have the funds in place to complete the
build-out of our Las Vegas cultivation and production facility. In addition, CLS will utilize a
portion of the proceeds to update its existing Oasis Cannabis dispensary location and improve its signage.
We are pleased to welcome Frank Tarantino as our Chief Financial Officer, at a key time with
our next phase in organic growth and acquisitions. Mr. Tarantino brings big four public accounting and private and public company
management and financial expertise, which will be extremely beneficial in leading our growth.
With our successful closing of the Oasis Cannabis acquisition, CLS is now active in the legalized cannabis market in
Las Vegas, NV. Oasis Cannabis is a fully integrated cannabis operation generating USD 850,000 in gross monthly revenue. Since 2017, Oasis has been involved in growing, extraction, conversion,
processing and operating a dispensary. Due to increased demand and the additional capital that was just raised, CLS plans to
triple the grow production capacity over the remainder of 2018 and into 2019. Oasis's City Trees wholesale product line recently
more than doubled its number of product SKUs offered to retail dispensary customers, and now covers a variety of concentrates,
vape pens, and capsules, and tinctures including high CBD versions. The City Trees product line is now being sold in over 20
dispensaries in the Las Vegas and Reno markets. As we add new
locations and expand our product manufacturing and cultivation facilities there will be more jobs created and additional
opportunities for our existing team to advance in their careers.
While our entrance and success in Nevada is key for the company, we are not satisfied with
resting on these milestones. We continue to explore additional opportunities for expansion in different states.
Our recently awarded non-provisional U.S. utility patent for cannabidiol extraction and conversion process by the United
States Patent and Trademark Office is a very significant milestone. The patent is directed to a process for the extraction of
cannabidiols from any variety of cannabis plants. The extraction process includes a sizing unit wherein raw cannabis plant
material is reduced to a uniform size, and a blending unit wherein an extraction solvent is blended together with the cannabis
plant material to form an initial extract. The conversion process, wherein the processed extract is combined and processed with
an acidic component, involves a separator unit in which solvent is added and a separator organic effluent is obtained. We believe
our strong intellectual property differentiates us from many of the operators out there. We will seek to license our proprietary
extraction and conversion methodology to other operators to be able to monetize it and help build long-term shareholder
value."
Aurora Cannabis Inc. (OTCQX: ACBFF) is one of the world's largest and leading cannabis companies. Aurora and
McGill University recently announced the launch of an international collaborative medical research
project that will comprehensively examine the therapeutic impact and human health outcomes of cannabidiol (CBD) oil as a therapy
for chronic pain and related anxiety and depression. The project that will be led by Dr. Gabriella
Gobbi, a leading researcher at the Faculty of Medicine of McGill University. Dr. Gobbi and her
team will work with a group of international research scientists at the Université Paris Descartes in France, and the Universities of Campania 'L.Vanvitelli' and Vita-Salute San
Raffaele in Italy. This three-year translational collaborative research project will investigate
the pain relief properties of CBD oil by exploring its mechanism of action in pain and associated depression and anxiety. "Based
on our extensive experience with more than 60,000 registered Canadian patients, we believe CBD to be one of the most impactful
medical compounds to become legally available to people in need of non-addictive therapies to treat pain," stated Terry Booth, Chief Executive Officer. "Our support for and involvement with this project underlines Aurora's
leadership in the medical cannabis space, as well as our long-term commitment to a science-based approach to deepen understanding
of this amazing substance."
iAnthus Capital Holdings Inc. (OTCQB: ITHUF) owns and operates best-in-class licensed cannabis cultivation,
processing and dispensary facilities throughout the United States, providing investors
diversified exposure to the U.S. regulated cannabis industry. iAnthus recently provided the following summary of updates to
inform shareholders and stakeholders of developments and achievements at GrowHealthy, the Company's Florida medical marijuana operation that was acquired earlier this year. Since the implementation of a
medical cannabis program in June 2017, the Florida market
continues to show strong growth. As of July 20th, 2018, the program has registered
138,558 patients and 1,572 qualified physicians, representing ~727% and ~92% growth, respectively. The program is adding
approximately 10,000 patients and 60 physicians per month. "As we prepare to open the first of our Florida dispensaries, we have made significant investments to upgrade our Lake
Wales cultivation facility to quickly scale production and meet the expected demand," said Carlos
Perea, Chief Operating Officer at iAnthus. "This expansion puts GrowHealthy in an excellent position to capitalize on the
explosive growth in the Florida medical marijuana market and become one of the state's
preeminent providers of medicinal cannabis products."
Emerald Health Therapeutics Inc. (OTCQX: EMHTF) is a Licensed Producer under Canada's
Access to Cannabis for Medical Purposes Regulations and produces and sells dried cannabis and cannabis oil for medical purposes.
Emerald Health recently announced that it has completed the purchase of the remaining shares of Northern Vine Canada Inc. from
Abattis Bioceuticals Corp. for USD 2 Million in cash and 1,093,938 common shares of Emerald. This
transaction, announced on July 19th, increases Emerald's ownership of Northern Vine from
65% to 100%. Northern Vine is a Licensed Dealer (LD) under the provisions of the Canadian Controlled Drugs and Substances Act.
The dealer license allows Emerald to participate in the growing market for cannabis analytical testing, which Emerald expects to
grow in conjunction with increasing cannabis production volumes in Canada. Northern Vine will
operate independently of Emerald and is committed to serving all clients, including Licensed Producers and patient-growers.
Legalization of cannabis for medical purposes and the upcoming legalization of cannabis for recreational purposes is expected to
drive demand for analytical testing services to assess potency and concentration of toxic materials. This acquisition also allows
Emerald to leverage Northern Vine's dealer license to advance research plans to develop cannabis formulations supporting new
products for both recreational purposes and to treat a broad spectrum of human conditions and diseases.
General Cannabis Corp. (OTCQX: CANN) is the comprehensive national resource for the highest quality service providers
available to the regulated cannabis industry. General Cannabis recently announced its financial results for the quarter ended
June 30th, 2018. "We broke the USD 1 Million revenue
ceiling in the second quarter of 2018, with revenues of USD 1,114,541, an increase of 34% over
2017. Year to date revenues increased 32% in 2018 over 2017," said Robert Frichtel, Chief
Executive Officer of General Cannabis. "Our Operations segment continues to find opportunities from the expansion of legalized
cannabis in numerous states, our Security segment is gaining traction in California, and
Chiefton's apparel business is achieving broader, national success," continued Mr. Frichtel. Furthermore, Michael Feinsod, Executive Chairman of General Cannabis, said, "I am confident that breaking the USD 1 Million quarterly revenue level in the second quarter is a proof of concept for our ability to be the
comprehensive national resource to the regulated cannabis industry. Our access to capital, our strong balance sheet and our
infrastructure expertise allow us to partner with companies throughout the industry, while positioning us to continue to expand
through acquisitions."
Subscribe Now! Watch us report LIVE https://www.youtube.com/FinancialBuzzMedia
Follow us on Twitter for real time Financial News Updates: https://twitter.com/financialbuzz
Follow and talk to us on Instagram: https://www.instagram.com/financialbuzz
Facebook Like Us to receive live feeds: https://www.facebook.com/Financialbuzz/
About FinancialBuzz.com
FinancialBuzz.com, a leading financial news informational web portal designed to provide the latest trends in Market News,
Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company
Interviews. A pioneer in the financially driven digital space, video production and integration of social media,
FinancialBuzz.com creates 100% unique original content. FinancialBuzz.com also provides financial news PR dissemination,
branding, marketing and advertising for third parties for corporate news and original content through our unique media platform
that includes Newswire Delivery, Digital Advertising, Social Media Relations, Video Production, Broadcasting, and Financial
Publications.
Please Note: FinancialBuzz.com is not a financial advisory or advisor, investment advisor or broker-dealer and do not
undertake any activities that would require such registration. The information provided on http://www.FinancialBuzz.com (the 'Site') is either original financial news or paid advertisements provided
[exclusively] by our affiliates (sponsored content), FinancialBuzz.com, a financial news media and marketing firm enters into
media buys or service agreements with the companies which are the subject to the articles posted on the Site or other editorials
for advertising such companies. We are not an independent news media provider and therefore do not represent or warrant that the
information posted on the Site is accurate, unbiased or complete. FinancialBuzz.com receives fees for producing and presenting
high quality and sophisticated content on FinancialBuzz.com along with other financial news PR media services. FinancialBuzz.com
does not offer any personal opinions, recommendations or bias commentary as we purely incorporate public market information along
with financial and corporate news. FinancialBuzz.com only aggregates or regurgitates financial or corporate news through our
unique financial newswire and media platform. For CLS Holdings USA Inc. financial news
dissemination and PR services, FinancialBuzz.com has been compensated five thousand dollars by the
company. Our fees may be either a flat cash sum or negotiated number of securities of the companies featured on this editorial or
site, or a combination thereof. The securities are commonly paid in segments, of which a portion is received upon engagement and
the balance is paid on or near the conclusion of the engagement. FinancialBuzz.com will always disclose any compensation in
securities or cash payments for financial news PR advertising. FinancialBuzz.com does not undertake to update any of the
information on the editorial or Site or continue to post information about any companies the information contained herein is not
intended to be used as the basis for investment decisions and should not be considered as investment advice or a recommendation.
The information contained herein is not an offer or solicitation to buy, hold or sell any security. FinancialBuzz.com, members
and affiliates are not responsible for any gains or losses that result from the opinions expressed on this editorial or Site,
company profiles, quotations or in other materials or presentations that it publishes electronically or in print. Investors
accept full responsibility for any and all of their investment decisions based on their own independent research and evaluation
of their own investment goals, risk tolerance, and financial condition. FinancialBuzz.com. By accessing this editorial and
website and any pages thereof, you agree to be bound by the Terms of Use and Privacy Policy, as may be amended from time to time.
None of the content issued by FinancialBuzz.com constitutes a recommendation for any investor to purchase, hold or sell any
particular security, pursue a particular investment strategy or that any security is suitable for any investor. This publication
is provided by FinancialBuzz.com. Each investor is solely responsible for determining whether a particular security or investment
strategy is suitable based on their objectives, other securities holdings, financial situation needs, and tax status. You agree
to consult with your investment advisor, tax and legal consultant before making any investment decisions. We make no
representations as to the completeness, accuracy or timeless of the material provided. All materials are subject to change
without notice. Information is obtained from sources believed to be reliable, but its accuracy and completeness are not
guaranteed. For our full disclaimer, disclosure and Terms of Use, please visit: http://www.financialbuzz.com .
Media Contact:
info@financialbuzz.com
+1-877-601-1879
Url: http://www.FinancialBuzz.com
SOURCE FinancialBuzz.com